Michael Deem

Houston, Texas, US

Michael Deem, a researcher, was appointed Director of Drug Design at CuraGen Corporation. He was responsible for coordinating a number of research programs to produce new medications for a broad range of injuries and diseases. Michael Deem would examine possible therapeutic targets, collaborate with a number of other scientists to determine which targets were practical, and coordinate financing for a number of research initiatives in an effort to launch new pharmaceutical products. This provided him with a vast amount of expertise in designing new pharmaceuticals from the ground up.